838 results found
View 10, 50, 100, 150 entries per page
Journal | Year | Drug | Authors | Title | Source |
---|---|---|---|---|---|
N Engl J Med | 2000 | Paint Thinner | Shannon M | Ingestion of toxic substances by children | N Engl J Med 2000 Jan 20; 342(3):186-91 |
Pediatrics | 1998 | Palivizumab | The IMpact-RSV Study Group | Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants | Pediatrics 1998 Sep; 102(3): 531-7 |
Clin Neuropharmacol | 2002 | Palivizumab | Mikati MA, Lepejian GA, Holmes GL | Medical treatment of patients with infantile spasms | Clin Neuropharmacol. 2002 Mar-Apr;25(2):61-71 |
Curr Opin Pulm Med | 2002 | Palivizumab | Greenough A | Respiratory syncytial virus infection: clinical features, management, and prophylaxis | Curr Opin Pulm Med. 2002 May;8(3):214-7 |
Respir Med | 2002 | Palivizumab | Simoes EA, Groothuis JR | Respiratory syncytial virus prophylaxis--the story so far | Respir Med. 2002 Apr;96 Suppl B:S15-24 |
Pediatr Infect Dis J | 2002 | Palivizumab | Oh PI, Lanctjt KL, Yoon A, Lee DS, Paes BA, Simmons BS, Parison D, Manzi P; Composs Investigators | Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes | Pediatr Infect Dis J. 2002 Jun;21(6):512-8 |
Pediatrics | 2003 | Palivizumab | Prais D, Schonfeld T, Amir J; Israeli Respiratory Syncytial Virus Monitoring Group | Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use | Pediatrics. 2003 Sep;112(3 Pt 1):548-52 |
J Pediatr | 2003 | Palivizumab | Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH Jr, Connor EM, Sondheimer HM; Cardiac Synagis Study Group | Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease | J Pediatr. 2003 Oct;143(4):532-40 |
Pediatrics | 2003 | Palivizumab | American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. | Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. | Pediatrics. 2003 Dec;112(6 Pt 1):1442-6. |
Pediatrics | 2003 | Palivizumab | Meissner HC, Long SS; American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn | Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections | Pediatrics. 2003 Dec;112(6 Pt 1):1447-52 |